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Inspired by the multi-functionality of vitamin D-binding protein and the multiple transient-
binding behavior of some intrinsically disordered proteins (IDPs), we have designed, prepared 
and characterized a polymeric platform for combined delivery of dermal protective and 
anticancer bioactive cargos based on artificial single-chain nano-objects mimicking IDPs. For 
the first time ever, simultaneous delivery of folic acid, or vitamin B9, and hinokitiol, a 
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relevant natural bioactive compound that exhibits anticancer activity against human malignant 
melanoma cells, from these multi-directionally self-assembled unimolecular nanocarriers is 
illustrated. 
 
1. Introduction  
The vitamin D-binding protein (DBP) or GC-globulin, identified about a half a century ago,
[1]
  
is a multi-functional protein found in human serum that binds and transports various forms of 
vitamin D, as well as other biomolecules like actin or fatty acids. DBP´s main function is to 
retain vitamin D for the organism and make it available to various tissues and cell types for 
usage.
[2]
 Various forms of vitamin D, such as D3 (cholecalciferol), D2 (ergocalciferol), 25D 
(25-hydroxy-vitamin D) and 1,25D (1,25-dihydroxy-vitamin D), the active form of vitamin D, 
are bound to DBP via a surface vitamin D-binding cleft in one of the three domains of the 
protein.
[3]
 The affinity constants for 25D-, 1,25D-, actin- and fatty acid-binding to BDP are 
7×10
8 
M
-1
, 4×10
7 
M
-1
, 1×10
9 
M
-1
 and 6-7×10
5 
M
-1
, respectively.
[4]
  
In contrast to globular proteins adhering to the classical structure-function paradigm, 
intrinsically disordered proteins (IDPs) lack a well-defined unique structure, adopting in 
solution a complete ensemble of rapidly interconverting conformations.
[5]
 Interestingly, in 
spite of its disordered structure, IDPs can bind several ligands, such as ions, small organic 
molecules, other proteins and nucleic acids (RNA, DNA). The interplay between structure and 
function in IDPs has not been recognized until very recently and it is not completely 
understood yet.
[6]
  Although some IDPs are simple coils that bond together other proteins, 
most of them have transient-binding or permanent-binding recognition sites. Moreover, a 
large number of IDPs exhibit what is referred to as binding promiscuity.
[7]
 
Recently, we have reported that the structure of multi-directionally self-assembled single-
chain polymer particles (SCNPs) under good solvent conditions closely resemble that of IDPs 
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in solution.
[8]
 Kratky plots from small angle neutron scattering (SANS) measurements showed 
a structure factor in close analogy to that of disordered multi-domain proteins (e.g., p67
phox
) 
so, from a structural point of view, they could be considered, to a good approximation, as 
artificial mimics of IDPs and denoted as IDPMs. It is worth mentioning that the Kratky plot 
has the capacity to enhance particular features of scattering profiles, thus allowing easier 
identification of degrees of compactness.
[5]
 Hence, according to SANS results SCNPs in good 
solvents show multiple local-scale domains separated by flexible linkers, whereas SCNPs in 
the dry state adopt a globular morphology, as observed by TEM. Moreover, in this previous 
study the ability of the SCNPs to deliver vitamin B9 in water at neutral pH was assessed. The 
delivery curve of vitamin B9 was fitted to a power law model from which the value of the 
release exponent was found to be ca. 0.5, suggesting that the process proceeds through a 
Fickian diffusion mechanism and completes in less than 5 hours.
[8]
  
We hypothesized that in analogy to some disordered proteins, IDPMs could also have 
some degree of binding promiscuity towards some relevant bioactive compounds that could 
be then delivered to water in a pH-dependent manner. In particular, we investigate herein the 
potential use of SCNPs as artificial IDPM nanocarriers for simultaneous delivery of both 
dermal protective and anticancer cargos (see Fig. 1A). As a model system of dermal 
protective compounds, we selected folic acid (also known as folate or vitamin B9), 1. 
According to several in vitro and in vivo studies, dermal delivery of 1 using topical 
formulations offers a treatment option for photo-aged skin.
[9,10]
 As a natural anticancer drug, 
we selected hinokitiol (β-thujaplicin), 2, as a tropolone-related compound found in heartwood 
of cupressaceous plants that exhibits anticancer activity against human malignant melanoma 
cells
[11]
 as well as other cancer cell lines, including the human leukemic cell K562 and the 
human stomach cancer cell KATO-III.
[12,13]
 The selective anticancer mechanism of 2 in 
melanoma cancer cells versus normal human melanocytes has been recently reported to 
involve strong G1 cell cycle arrest due to p27 protein accumulation, down-regulation of Skp2 
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proteins, and inhibition of Cdk2 kinase activity.
[14]
 As a proof of concept we will demonstrate, 
for the first time ever, the simultaneous delivery of 1 and 2 to water solutions at different pH 
values from SCNPs as artificial IDPM nanocarriers. 
 
2. Results and Discussion 
 
2.1. Design of intrinsically disordered protein mimetics (IDPMs) 
The design of intrinsically disordered protein mimetics, IDPMs, was guided by molecular 
dynamics (MD) simulations. In particular, coarse-grained MD simulations were performed to 
investigate the effect of different parameters, such as precursor chain length and functionality 
of reactive groups along the chain on the final structure and morphology of the resulting 
IDPMs in solution. A detailed description of the MD simulations performed is provided in the 
Supplementary Information (SI). In brief, a precursor chain of N beads of radius  having a 
fraction of monomers x = 0.2 of functionality f, able to form permanent intrachain cross-links, 
was first equilibrated as a self-avoiding random walk (i.e. good solvent conditions). Then, 
MD simulations were carried out allowing the progressive formation of irreversible links 
between reactive monomers in the chain if the distance between monomers is lower than a 
certain capture radius (1.3). Once the intrachain cross-linking process was completed, the 
average radius of gyration (Rg) of the resulting nano-objects was determined.
[15-21]
 
Based on the MD simulation results, IDPM size was found to depend more strongly on 
precursor length than on the functionality of the reactive groups. In order to define the 
structure of the nanoparticles taking into account multi-body correlations among the 
monomers, we use the Euler characteristic as a topological fingerprint 
[22,23]
. In Fig. 2 we can 
observe a deep minimum (R ≈ 0.5σ) which give us informations on the typical (limited) hole 
size. The deep minimum and the lack of any further positive peak suggest an elongated sparse 
structure instead of a compact, globular structure. No significant differences in the typical 
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morphology of the resulting IDPMs were observed by increasing the functionality of the 
reactive groups in the polymer precursor. On the other hand, a broad range of morphologies 
were observed as a consequence of the statistical placement of reactive groups along the 
individual chains and the stochastic nature of the cross-linking process (see Fig. S1). Both the 
precursor chains and the nano-objects follow a Rg
2
  N2 scaling law; the values of the  
exponent were found to be  = 0.63 ± 0.01,  = 0.57 ± 0.01 and  = 0.55 ± 0.01 for the 
precursor, bifunctional and trifunctional cross-linked nanoparticles, respectively (see Fig. S2). 
Hence, the reduction in size upon IDPM formation from the linear precursor was found to 
grow with increasing precursor size. Based on the obtained scaling laws, precursor chains (f = 
3) of N = 100 and N = 3000 will show Rg
(IDPM)
 / Rg
(Precursor)
 ratios of 0.75 and 0.59, 
respectively.  
 
2.2. Preparation and characterization of IDPMs 
Guided by the MD simulation results, we target a precursor molecular weight of 3 × 10
5
 Da 
having a representative amount of cross-linking groups of 25 mol % for which we expect a 
Rg
(IDPM)
 / Rg
(Precursor)
 ratio of 0.59 when collapsed to individual IDPM under good solvent 
conditions. Such a high molecular weight will allow us to determine the evolution of Rg 
during IDPM formation via SEC/SLS measurements. In this sense, SEC chromatography 
discriminates macromolecules according to their hydrodynamic radius (Rh) which is roughly 
inversely proportional to SEC elution time (tR), whereas the SLS technique provides values of 
both absolute molecular weight (Mw) and Rg. The polymer precursor was synthesized from 
commercially available methyl methacrylate (MMA) and (2-acetoacetoxy)ethyl methacrylate 
(AEMA) monomers via RAFT copolymerization (see Fig. 1B), showing an average Rg = 14.8 
± 0.5 nm, relatively narrow polydispersity (Mw / Mn = 1.37) and a random distribution of 
reactive -ketoester moieties from AEMA repeat units, as determined by 1H NMR 
spectroscopy. To construct the IDPMs, the polymer precursor was individually collapsed 
    
 - 6 - 
under controlled stoichiometric and dilution conditions in tetrahydrofuran (THF) at r.t. 
through multidirectional Michael addition reactions involving the single-chain -ketoester 
groups, as Michael donors, and external acrylate-based cross-linkers of functionality f = 3, as 
Michael acceptors.
[8]
 This method produces robust, covalent bonded single-chain nano-
objects.
[24, 25]
 The effect of precursor concentration during the synthesis of IDPMs on nano-
object size and size distribution is summarized in Table 1, as determined by combined 
SEC/SLS and complementary DLS measurements. By working at 3 mg/ml, an increase in the 
value of the actual molecular weight was observed even when a moderate reduction in the 
values of Rh and Rg was clearly observed. Upon decreasing the precursor concentration to 1 
mg/ml, the absolute molecular weight values at the SEC peak maximum of the precursor and 
the IDPMs were found to be very similar, and a larger reduction in the values of Rh and Rg 
was found. No further reduction was observed by working at precursor concentrations < 1 
mg/ml. In this sense, it is worth mentioning that potential intermolecular cross-linking events 
are increasingly avoided by passing from a semi-concentrated to a highly diluted 
solution.
[26,27]
 A vertical shift (downward) in the curve of Rg versus tR was observed upon 
nano-object formation (see Fig. 3A) which can be attributed to a change in the Rg/Rh ratio on 
passing from linear coils to IDPMs. For a flexible polymer chain under good solvent 
conditions Rg/Rh ≈ 1.56, whereas for globular particles Rg/Rh ≈ 0.77.
[28]
 IDPMs synthesized at 
3 mg/ml show a ratio of Rg/Rh = 1.25, whereas IDPMs synthesized at 1 mg/ml display Rg/Rh 
= 1.05, the latter being a value intermediate between those expected for a coil and a globule. 
The collapse degree (Rg
(IDPM)
 / Rg
(Precursor)
) for nanoparticles (f = 3) synthesized at 1 mg/ml 
was 0.55, in good agreement with the value estimated from MD simulations. According to 
data summarized in Table 1, IDPM-1 shows a structure more collapsed than IDPM-3. 
The typical morphology of the IDPMs under good solvent conditions was deduced 
from SAXS measurements, showing a Kratky plot resembling that observed in natural 
intrinsically disordered proteins and very different from that of the linear precursor (see Fig. 
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3B).
[5]
 As expected, SAXS results were in good agreement with previous SANS and MD 
simulation data.
[8]
 Conversely, the morphology of individual IDPMs in the dry state was 
undoubtedly globular, as observed by TEM, showing collapsed nanoparticles with a spherical 
shape (Fig. 3C). 
 
 
2.3. Combined delivery of dermal bioactive cargos from IDPMs 
To test our hypothesis of IDPM multi-binding ability, the nanocarriers were loaded with both 
folic acid (1) and hinokitiol (2) and the controlled delivery of these protective and anticancer 
dermal bioactive cargos, respectively, in water at two relevant pH values (pH = 6 and pH = 8) 
was monitorized by UV spectroscopy. For quantifying the delivery process, the intensities of 
the UV absorption maxima of 1 and 2 at 283 nm and 240 nm, respectively, as well as 
appropriate calibration curves, were employed (see Figs. S3, S4). Figure 3D illustrates the 
experimental data corresponding to the simultaneous delivery of 1 and 2 at pH = 6 and pH = 8 
from IDPMs loaded with 51 % of dermal bioactive compounds (ratio 2 : 1 = 0.53). According 
to these data, on average, there are 410 molecules of 2 and 170 molecules of 1 per IDPM 
carrier. The delivery process for both compounds was faster at pH = 8 than at pH = 6, 
especially at short delivery time, whereas total delivery was found to take place in about 4 
hours at both pH values. All our attempts to characterize the presumably weak 1/IDPM and 
2/IDPM interactions under the high diluted experimental conditions by 
1
H NMR, UV-vis and 
FTIR spectroscopies failed. Nevertheless, the simultaneous delivery of 1 and 2 to water 
solutions at relevant pH values from SCNPs as artificial IDPM nanocarriers pave the way to 
the long-term development of multifunctional topical formulations containing IDPMs. 
 
3. Conclusion 
Guided by MD simulations results we have developed and characterized single-chain 
nanocarriers mimicking disordered proteins (IDPMs) for combined delivery of dermal 
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bioactive cargos. Hence, MD simulations results have shown that IDPM size depends more 
strongly on precursor length than on the functionality of the reactive groups in the precursor. 
By using the Euler characteristic as a topological fingerprint, we have found that the average 
hole size is similar to the bead size employed in the simulations. Snapshots of the IDPMs 
showed elongated sparse estructures instead of compact, globular morphologies displaying 
Rg
(IDPM)
 / Rg
(Precursor)
 ratios between 0.75 and 0.59 depending on the precursor length. Good 
agreement was found between the collapse degree of IDPMs synthesized via Michael 
addition-induced self-assembly (Rg
(IDPM)
 / Rg
(Precursor)
 = 0.55) and the value estimated from 
MD simulations (Rg
(IDPM)
 / Rg
(Precursor)
 = 0.59) when intrachain cross-linking was carried out at 
high dilution. SAXS measurements supported the MD simulation results showing an IDPM 
form factor in the Kratky plot similar to that observed in natural disordered proteins. TEM 
pictures, however, displayed a globular IDPM morphology upon drying, pointing to a 
transition from extended to compact nano-objects when solvent was removed. The multi-
binding ability of the single-chain nano-objects was demonstrated by simultaneous delivery of 
hinokitiol and folic acid to water solutions at relevant pH values paving the way to the 
development of multifunctional topical formulations containing IDPMs. 
 
Acknowledgements: Financial support from the projects MAT2012-31088 (MINECO) and IT-
654-13 (GV) is acknowledged. A. S.-S. thanks the PhD grant support of Basque Government. 
 
Received:  
Revised:  
Published online:  
DOI: 10.1002/marc.201300562 
 
Keywords: Nanocarriers; self-assembly; nanoparticles; nanomedicine; drug delivery. 
 
    
 - 9 - 
[1] J. Hirschfeld, Phatol. Microbio. Scand., 1959, 47, 160. 
[2] R. Bouillon, “The Vitamin D Binding Protein DBP”, In Vitamin D (3rd edn.), Vol. 1; 
Academic Press, London, 2011. 
[3] R. A. Laskowski, N. M. Luscombe, M. B. Swindells, J. M. Thornton, Protein Sci., 1996, 
5, 2438.  
[4] R. F. Chun, Cell Biochem. Funct., 2012, 30, 445. 
[5] P. Bernado, D. I. Svergun, Mol. BioSyst., 2012, 8, 2955. 
[6] P. Tompa, K.-H. Han, Phys. Today, 2012, 65, 64. 
[7] V. N. Uversky, BBA-Proteins. Proteom., 2013, 1834, 932.  
[8] A. Sanchez-Sanchez, S. Akbari, A. Etxeberria, A. Arbe, U. Gasser, A. J. Moreno, J. 
Colmenero, J. A. Pomposo, ACS Macro Lett., 2013, 2, 491. 
[9] A.Knott, H. Mielke, U. Koop, R. Wolber, T. Burkhardt, J.-P.Vietzke, F. Stäb, H. Wenck, 
S. Gallinat, J. Invest. Dermatol., 2007, 127, 2463.  
[10] F. Fischer, V. Achterberg, A. März, S. Puschmann, C.-D. Rahn, V. Lutz, A. Krüger, H. 
Schwengler, S. Jaspers, U. Koop, T. Blatt, H. Wenck, S. Gallinat, J. Cosmet. Dermatol. 2011, 
10, 15. 
[11] T. Baba, H. Nakano, K. Tamai, D. Sawamura, K. Hanada, I. Hashimoto, Y. Arima, J. 
Invest. Dermatol., 1998, 110, 24. 
[12] Y. Inamori, H. Tsujibo, H. Ohishi, F. Ishii, M. Mizugaki, H. Aso, N. Ishida, Biol. Pharm. 
Bull., 1993, 16, 521.  
[13] D. Miyamoto, N. Endo, N. Oku, Y. Arima, T. Suzuki, Y. Suzuki, Biol. Pharm. Bull., 
1998, 21, 1258.  
[14] S. Liu, H. Yamauchi, Cancer Lett. 2009, 286, 240. 
[15] K. Kremer, G. S. Grest, J. Chem. Phys., 1990, 92, 5057. 
[16] M. P. Allen, D. J. Tildesley, Computer simulation of liquids, Oxford University Press, 
Oxford (UK), 1989. 
    
 - 10 - 
[17] J. A. Izaguirre, D. P. Catarello, J. M. Wozniak, R. D. Skeel, J. Chem. Phys., 2001, 114, 
2090. 
[18] D. R. Rottach, J. G. Curro, J. Budzien, G. S. Grest, C. Svaneborg, R. Everaers, 
Macromolecules, 2006, 39, 5521. 
[19] B. Capone, I. Coluzza, F. Lo Verso, C. N. Likos, R. Blaak, Phys. Rev. Lett., 2012, 109, 
238301. 
[20] F. Lo Verso, A. Z. Panagiotopoulos, C. N. Likos, Phys. Rev. E, 2009, 79, 010401. 
[21] C. Koch, C. N. Likos, A. Z. Panagiotopoulos, F. Lo Verso, Mol. Phys., 2011, 109, 3049. 
[22] C. N. Likos, K. R. Mecke, and H. Wagner,  J. Chem. Phys., 1995, 102, 9350. 
[23] N. Hoffmann, F. Ebert, C. N. Likos, H. Lowen, and G. Maret, Phys. Rev. Lett., 2006, 97, 
078301. 
[24] A. Sanchez-Sanchez, I. Pérez-Baena, José A. Pomposo, Molecules, 2013, 18, 3339. 
[25] O. Altintas, C. Barner-Kowollik, Macromol. Rapid Commun., 2012, 33, 958.   
[26] a) E. Harth, B.V. Horn, V.Y. Lee, D.S. Germack, C.P. Gonzales, R.D. Miller, C. J. 
Hawker, J. Am. Chem. Soc., 2002, 124, 8653; b) B. T. Tuten, D. Chao, C. K. Lyon, E. B. 
Berda, Polym. Chem., 2012, 3, 3068; c) I. Perez-Baena, F. Barroso-Bujans, U. Gasser, A. 
Arbe, A. J. Moreno, J. Colmenero, J. A. Pomposo, ACS Macro Lett., 2013, 2, 775. 
[27] a) J. A. Pomposo, I. Perez-Baena, L. Buruaga, A.  Alegría, A. J. Moreno, J. Colmenero, 
Macromolecules, 2011, 44, 8644; b) D. Chao, X. Jia, B. Tuten, C. Wang, E. B. Berda, Chem. 
Commun., 2013, 49, 4178. 
[28] Y. Oono, M. Kohmoto, J. Chem. Phys., 1983, 78, 520. 
 
 
Tables 
 
 
    
 - 11 - 
 
Table 1. Effect of precursor concentration on nanocarrier size during the synthesis of 
intrinsically disordered protein mimetics (IDPMs). 
System tR (min)
a
 Mw (Da)
b
 Mw / Mn Rg (nm)
c 
Rh 
(nm)
d 
Rg / Rh 
Precursor 6.59 3.02 × 10
5 
1.37 14.8 10.1 1.47 
IDPM-3
e
 6.76 3.22 × 10
5
 1.33 10.6 8.5 1.25 
IDPM-1
f
 6.85 2.83 × 10
5
 1.15 8.1 7.7 1.05 
a
SEC retention time. 
b
Absolute molecular weight at the SEC peak maximum. 
c
Determined by SLS at the SEC 
peak maximum. 
d
Determined by DLS. 
e
Synthesis of IDPMs performed at 3 mg/ml. 
f
Synthesis of IDPMs 
performed at 1 mg/ml. 
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Fig. 1 A) Chemical structures of folic acid (1) and hinokitiol (2). B) Chemical structure of the 
single-chain nanocarrier precursor (3).  
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Fig. 2 Euler characteristic χ(R) of intrinsically disordered protein mimetics (IDPMs) as a 
function of R/Rg. R is the appropriate length scale characterizing the size of the family of 
surfaces constructed from a given configuration of particles (see SI for details). IDPM 
configurations were determined from coarse-grained MD simulations under good solvent 
conditions for nanocarriers of N = 400, x = 0.2, f = 2, <Rg
2
>
1/2
 = 15.8σ, and N = 400, x = 0.2, 
f = 3, <Rg
2
>
1/2
 = 15.3σ.
 
The snapshots represent typical conformations for f = 3 (top) and f = 2 
(bottom). (N = number of beads, x = fraction of reactive groups in the chain, f = functionality, 
number of reactive groups that are allowed to be bonded per cross-linking point, Rg = radius 
of gyration). 
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Fig. 3 Synthesis and characterization of intrinsically disordered protein mimetics (IDPMs) 
allowing simultaneous delivery of both dermal protective and anticancer cargos: A) 
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Illustration of SEC/SLS data for the precursor (red lines), IDPMs synthesized at 3 mg/ml 
(blue lines) and IDPMs synthesized at 1 mg/ml (green lines). For each SEC trace, the value of 
Rg at the peak maximum is indicated by a black circle. B) Kratky plot from small angle X-ray 
scattering (SAXS) measurements in THF of the precursor (blue line) and the corresponding 
IDPMs (green line). C) TEM picture showing the spherical shape of IDPMs onto a carbon-
coated grid upon solvent removal. D) Simultaneous delivery data in water at pH = 6 (blue 
symbols) and pH = 8 (red symbols) of folic acid, 1, (open symbols) and hinokitiol, 2, (solid 
symbols) from IDPMs. 
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Simultaneous delivery of both dermal protective (folic acid) and anticancer (hinokitiol) 
cargos is reported from artificial intrinsically disordered protein mimics based on multi-
directionally self-assembled single-chain nanocarriers. 
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